PCT fights Herceptin approval

July 12, 2006

A primary care trust has appealed against the NICE recommendation of Herceptin, apparently challenging how many women should receive the …

MabThera approved for rheumatoid arthritis

July 11, 2006
Sales and Marketing

Roche's blockbuster cancer drug MabThera has gained European marketing approval to treat rheumatoid arthritis.First launched in 1997, MabThera (rituximab) made …

Avastin filed for breast cancer treatment

July 10, 2006
Sales and Marketing

Roche's Avastin could be licensed to treat advanced breast cancer in Europe by early 2007, following its filing with regulator …

Lilly to close UK manufacturing site but retains R&D operations

July 7, 2006
Manufacturing and Production

Pharmaceutical company Lilly is to close its UK manufacturing facility in Basingstoke with as many as 300 employees expected to …

Anti-smoking ad lights up Best of Health awards

July 7, 2006
Medical Communications Best of Health, advertising, awards, events

Clear Marketing Communications has taken the top prize at the 2006 Best of Health Awards with a striking advert highlighting …

Work progressing on Scotland’s ‘unique’ biotech campus

July 7, 2006
Research and Development

Plans to make Scotland a major centre for innovative biotech and pharmaceutical research are progressing, with a major new centre …

Company behind Northwick Park trial files for insolvency

July 7, 2006
Sales and Marketing

The pharmaceutical company behind TGN 1412, the drug which caused near-fatal reactions in six clinical trials volunteers at Northwick Park, …

Practice-based commissioning uptake exaggerated, say GPs

July 7, 2006

Doctors' leaders have challenged claims by the government that as many as 40% of GPs are engaged in practice-based commissioning, …

Venomous snail provides Eisai with new painkiller

July 7, 2006
Research and Development, Sales and Marketing

Patients suffering severe chronic pain have new hope of relief thanks to a venomous sea snail found off the coast …

Scotland NHS appoints first private provider

July 6, 2006

Scotland's health service is set to appoint its first private provider to cut surgery waiting times, following the controversial policy …

CRM and keeping up with your customers

July 6, 2006
Sales and Marketing CRM, customer relationship management, sales

Customer relationship management systems are now universally used by major pharmaceutical companies, in fact many have several.Evolving from their beginnings …

Patents: extending the golden years

July 5, 2006
Sales and Marketing patents, sales, strategy

Much like death and taxes, one of the certainties of this world is that patents expire, and if a product …

Hepatitis B treatment Baraclude approved in Europe

June 30, 2006
Sales and Marketing

A new hepatitis B treatment Baraclude has been approved in Europe and could eventually become a first-line choice thanks to …

Acomplia launched in UK

June 29, 2006
Sales and Marketing

Acomplia, the long-awaited weight-loss drug from Sanofi-Aventis has been launched in the UK, and promises to help patients shed pounds …

Generic company fails to overturn Lipitor patent in UK

June 29, 2006
Sales and Marketing generics

A legal challenge to overturn Pfizer's UK patent on its top-selling cholesterol treatment has failed.Lipitor is the biggest selling drug …

New COPD standards to tackle inequalities

June 29, 2006
Sales and Marketing

New national standards for the treatment of one of the biggest killers in the UK have been launched, with a …

Gene therapy: the tailor-made treatment

June 28, 2006
Research and Development drug development, gene therapy

 At the risk of boring my audience, I really can't help beginning with yet another attack of nostalgia ,or rather …

Calling up reinforcements

June 28, 2006
Business Services interim management, recruitment

In the pharmaceutical industry outsourcing has never enjoyed greater popularity and all the indications are that this trend is set …

New drug for treatment-resistant HIV approved

June 28, 2006
Sales and Marketing

Prezista, a new drug for patients who have treatment-resistant HIV, has been approved in the US.The treatment from Johnson & …

Novartis to market new vaccine for Japanese encephalitis

June 28, 2006
Sales and Marketing

Novartis has licensed the marketing rights to a phase III vaccine from Intercell for Japanese encephalitis virus infections. The vaccine …

The Gateway to Local Adoption Series

Latest content